Skip to main content
. Author manuscript; available in PMC: 2017 Aug 1.
Published in final edited form as: Aliment Pharmacol Ther. 2016 Jul 3;44(4):380–389. doi: 10.1111/apt.13707

Table 1.

Patient Baseline Characteristics

Characteristic HBeAg positive
(n=22)
HBeAg negative
(n=20)
p value

Age (years)* 47 (14–67) 48 (17–71) 0.85

Male Sex 20 (91%) 16 (80%) 0.40

Race: White or Caucasian 13 9
  Black or African-American 1 2 0.56
  Asian-American 8 9

Source: Sexual 10 3
  Maternal-Infant 7 15 0.03
  Transfusion 2 0
  Other or Unknown 3 2

ALT (U/L)* 106.5 (28–524) 99.5 (39–336) 0.65

AST (U/L)* 69 (25–331) 64.5 (25–171) 0.42

Bilirubin (mg/dL)* 0.6 (0.3–3.0) 0.5 (0.3–1.8) 0.45

Albumin (g/dL)* 4.1 (1.7–4.6) 4.1 (2.9–4.7) 0.90

Prothrombin time (sec)* 12.6 (11.3–13.6) 13.4 (11.8–15.0) 0.01

Platelet count (per µL)* 187 (113–346) 174.5 (33–328) 0.43

APRI* 1.3 (0.2–6.2) 1.4 (0.3–12.9) 0.74

HBV DNA (log IU/mL)* 9.2 (7.3–10.4) 7.4 (5.3–9.5) <0.001

HBsAg concentration (log IU/mL)* 3.9 (2.0–5.3) 2.9 (1.9–4.0) 0.02

Genotype: A 15 6
  C 7 8 0.008
  D 0 5
  E 0 1

HAI score (0–18)* 10.5 (3–17) 12.0 (5–14) 0.92

Ishak score (0–6)* 4 (0–6) 3 (0–6) 0.05

Cirrhosis (Ishak 5 or 6) 8 (36%) 5** (25%) 0.51
*

Median (range).

**

Imputed for one case.